Technical Analysis for LMNX - Luminex Corporation

Grade Last Price % Change Price Change
B 36.65 0.08% 0.03
LMNX closed up 0.08 percent on Thursday, May 13, 2021, on 78 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Flat
Historical LMNX trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 11.23%
Bollinger Band Squeeze Range Contraction 11.23%
20 DMA Resistance Bearish 13.54%
Bollinger Band Squeeze Range Contraction 13.54%
Narrow Range Bar Range Contraction 13.54%
NR7 Range Contraction 13.54%
NR7-2 Range Contraction 13.54%
BB Squeeze Started Range Contraction 13.54%
NR7 Range Contraction 15.47%
NR7-2 Range Contraction 15.47%
Older End-of-Day Signals for LMNX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Luminex Corporation Description

Luminex Corporation engages in the development, manufacture, and sale of proprietary biological testing technologies and products for the life sciences and diagnostic industries. It offers xMAP technology, an open architecture and multiplexing technology that allows simultaneous analysis of approximately 500 bioassays from a drop of fluid by reading biological tests on the surface of microscopic polystyrene beads called microspheres; and MultiCode technology used for real-time polymerase chain reaction (PCR) and multiplexed PCR assays, as well as automation and robotics in the field of dry sample handling. It operates in two segments, Technology and Strategic Partnerships; and Assays and Related Products. The Technology and Strategic Partnerships segment provides Luminex LX 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; and MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids. This segment also offers consumables comprising dyed polystyrene microspheres and sheath fluids. The Assays and Related Products segment develops and sells assays on xMAP technology for use on its installed base of systems. This segment's products are focused on the human genetics, personalized medicine, and infectious disease segments of the genetic testing market. This segment provides various assay products, which consist of a combination of chemical and biological reagents, and company's proprietary bead technology used to perform diagnostic and research assays on samples. It serves pharmaceutical companies, clinical laboratories, research institutions, and medical institutions in the United States, Europe, Asia, Canada, and Australia. The company has a collaboration and license agreement with Merck & Co., Inc. to develop a companion diagnostic device. Luminex Corporation was founded in 1995 and is headquartered in Austin, Texas.


Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Life Sciences Pharmaceutical Acid Chemical Natural Sciences Genetics Optics Robotics Multiplex Acids Infectious Disease Multiplexing Signal Processing Companion Diagnostic Styrene Genetic Testing Laboratory Techniques Polymerase Chain Reaction Digital Signal Processing Nucleic Acids Personalized Medicine Fluidics Real Time Polymerase Chain Reaction Luminex Corporation Testing Technologies

Is LMNX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 41.69
52 Week Low 20.61
Average Volume 1,267,800
200-Day Moving Average 28.39
50-Day Moving Average 34.48
20-Day Moving Average 36.73
10-Day Moving Average 36.73
Average True Range 0.51
ADX 36.98
+DI 27.35
-DI 12.33
Chandelier Exit (Long, 3 ATRs ) 35.62
Chandelier Exit (Short, 3 ATRs ) 38.00
Upper Bollinger Band 36.89
Lower Bollinger Band 36.56
Percent B (%b) 0.27
BandWidth 0.90
MACD Line 0.66
MACD Signal Line 0.86
MACD Histogram -0.1996
Fundamentals Value
Market Cap 1.71 Billion
Num Shares 46.5 Million
EPS 0.40
Price-to-Earnings (P/E) Ratio 92.09
Price-to-Sales 2.66
Price-to-Book 2.09
PEG Ratio 0.70
Dividend 0.36
Dividend Yield 0.98%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 36.98
Resistance 3 (R3) 36.97 36.84 36.93
Resistance 2 (R2) 36.84 36.76 36.85 36.91
Resistance 1 (R1) 36.75 36.71 36.80 36.76 36.89
Pivot Point 36.62 36.62 36.65 36.63 36.62
Support 1 (S1) 36.53 36.54 36.58 36.54 36.41
Support 2 (S2) 36.40 36.49 36.41 36.39
Support 3 (S3) 36.31 36.40 36.38
Support 4 (S4) 36.32